**
Recent findings reveal that NHS cancer nurses are being exposed to hazardous chemicals associated with increased risks of miscarriage and infertility, primarily due to insufficient personal protective equipment (PPE). An investigation conducted by The Independent and Channel 4 News has highlighted the alarming inadequacy of safety measures in place for healthcare workers who administer toxic treatments such as chemotherapy.
A Growing Health Crisis
Tens of thousands of healthcare professionals across the NHS are engaged in administering potent medications for various conditions including cancer, rheumatoid arthritis, HIV, and multiple sclerosis. Disturbingly, many of these workers are equipped with only basic protection—plastic aprons and gloves—leaving them vulnerable to the harmful effects of these substances. Nurses have reported a range of health issues, including recurrent miscarriages, hair loss, dizziness, and fatigue, which they suspect may be linked to their work environment.
In September 2025, the NHS West Midlands Cancer Alliance issued guidance cautioning that inadequate protective measures could lead to severe health consequences including miscarriages, birth defects, and abnormal cell formations. This aligns with findings from multiple studies that indicate a correlation between exposure to these drugs and fertility problems among healthcare staff. Comparatively, the United States has seen the Centres for Disease Control and Prevention issue alerts regarding similar risks, yet UK protocols allow NHS trusts to provide the bare minimum in terms of protection for their employees.
Personal Accounts of Risk
Alison Simons, a cancer nurse with over 20 years of experience, shared her distressing journey regarding her health and miscarriages. Initially unaware of the potential link between her work and her reproductive health, it was only through discussions with colleagues that she realised the troubling pattern among them. “It’s particularly frustrating because we know there are things out there to protect us, and they’re not being used. It does beg the question, are we not worth it?” she expressed, highlighting a deep concern about the prioritisation of staff safety.
Similarly, Samantha Toland, who has spent 26 years in cancer care, voiced her struggles and the shared experiences of her peers. “I’ve had colleagues who have had multiple miscarriages, up to six or seven,” she lamented, stressing the importance of adequate protective measures. This sentiment echoes throughout the healthcare community, where there is a consensus that the current level of protection is grossly inadequate.
Regulatory Gaps and Calls for Change
Professor Karen Campbell, a prominent figure in oncology nursing, underscored that the risks associated with chemotherapy agents have been recognised for decades. Her recent research revealed that 97% of participating nurses primarily received only plastic aprons while administering these hazardous drugs. Alarmingly, a mere 62% were provided with the appropriate chemotherapy gloves, and 53% were given general-purpose gloves, which do not offer the necessary protection.
Despite the availability of safer practices, such as closed system transfer devices designed to minimise exposure during drug preparation and administration, only 44% of healthcare workers reported consistent use of these safeguards. Professor Campbell remarked on the reluctance of regulatory bodies to standardise protective practices, raising concerns about the long-term health impacts on a predominantly young, female workforce.
Labour MP Luke Akhurst, who has undergone chemotherapy himself, has raised this critical issue with government officials, asserting the moral obligation to safeguard healthcare workers who are vital in treating those with life-threatening conditions. He stated, “This is about the NHS staff who are there for when you are really acutely ill… None of us want the staff who are helping us to have their health damaged.”
The Royal College of Nursing has also called for the Health and Safety Executive (HSE) to implement stricter standards for handling hazardous medications. Current regulations allow for exposure to be maintained at “as low as reasonably practical,” a subjective measure that has led to inconsistent practices across NHS trusts. The RCN advocates for a shift to “the lowest possible level” of exposure, demanding stronger controls to protect workers.
Conclusion and the Need for Action
The NHS has stated its commitment to staff safety, emphasising the legal responsibility of trusts to protect employees from exposure to hazardous substances. However, as the investigation uncovers a worrying trend of negligence, it is clear that urgent action is required to address these pressing health risks facing cancer nurses.
Why it Matters
The ongoing exposure of NHS cancer nurses to toxic substances without adequate protection not only jeopardises their health but also undermines the integrity of the healthcare system. As these dedicated professionals continue to provide critical care to patients battling serious illnesses, it is imperative that their safety is prioritised. Ensuring proper protective measures is not only a matter of workplace safety but a moral obligation to safeguard those who tirelessly work to save lives. Without immediate intervention, the NHS risks losing valuable staff and compromising patient care in the process.